Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Huber

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Frontiers in Psychology|August 4, 2015
Mental health problems in adolescents with cochlear implants: peer problems persist after controlling for additional handicapsMaria Huber, Thorsten Burger, Angelika Illg, et al.
The World Allergy Organization Journal|October 18, 2022
Response to high-altitude triggers in seasonal asthmatics on and off inhaled corticosteroid treatmentPontus Mertsch, Jeremias Götschke, Julia Walter, et al.
International Immunopharmacology|August 18, 2004
Triacyl-lipopentapeptide adjuvants: TLR2-dependent activation of macrophages and modulation of receptor-mediated cell activation by altering acyl-moietiesSilke D C Müller, Markus R Müller, Maria Huber, et al.
ERJ Open Research|October 21, 2021
BreathEase: rationale, design and recruitment of a randomised trial and embedded mixed-methods study of a multiprofessional breathlessness service in early palliative careMichaela Schunk, Ursula Berger, Lien Le, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 24, 2014
Efficacy of the irreversible ErbB family blocker afatinib in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-pretreated non-small-cell lung cancer patients with brain metastases or leptomeningeal diseasePetra Hoffknecht, Amanda Tufman, Thomas Wehler, et al.
Frontiers in Immunology|August 7, 2023
Retained avidity despite reduced cross-binding and cross-neutralizing antibody levels to Omicron after SARS-COV-2 wild-type infection or mRNA double vaccinationTeresa Harthaller, Barbara Falkensammer, David Bante, et al.
Leukemia Research|February 14, 2012
The clinical impact of DNA methylation frequencies of JAK2 negative regulators in patients with essential thrombocythemiaMathilde Födermayr, Otto Zach, Maria Huber, et al.
BMC Cancer|July 9, 2016
Interleukin-22 is elevated in lavage from patients with lung cancer and other pulmonary diseasesAmanda Tufman, Rudolf Maria Huber, Stefanie Völk, et al.
Vaccine|February 9, 2007
Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccineRoland Grunow, Mustafa Porsch-Ozcürümez, Wolf Splettstoesser, et al.
Plos One|December 3, 2015
Correction: Risk Factors for Mercury Exposure of Children in a Rural Mining Town in Northern ChileJohan Ohlander, Stella Maria Huber, Michael Schomaker, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Frontiers in Psychology|August 4, 2015
Mental health problems in adolescents with cochlear implants: peer problems persist after controlling for additional handicapsMaria Huber, Thorsten Burger, Angelika Illg, et al.
The World Allergy Organization Journal|October 18, 2022
Response to high-altitude triggers in seasonal asthmatics on and off inhaled corticosteroid treatmentPontus Mertsch, Jeremias Götschke, Julia Walter, et al.
International Immunopharmacology|August 18, 2004
Triacyl-lipopentapeptide adjuvants: TLR2-dependent activation of macrophages and modulation of receptor-mediated cell activation by altering acyl-moietiesSilke D C Müller, Markus R Müller, Maria Huber, et al.
ERJ Open Research|October 21, 2021
BreathEase: rationale, design and recruitment of a randomised trial and embedded mixed-methods study of a multiprofessional breathlessness service in early palliative careMichaela Schunk, Ursula Berger, Lien Le, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 24, 2014
Efficacy of the irreversible ErbB family blocker afatinib in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-pretreated non-small-cell lung cancer patients with brain metastases or leptomeningeal diseasePetra Hoffknecht, Amanda Tufman, Thomas Wehler, et al.
Frontiers in Immunology|August 7, 2023
Retained avidity despite reduced cross-binding and cross-neutralizing antibody levels to Omicron after SARS-COV-2 wild-type infection or mRNA double vaccinationTeresa Harthaller, Barbara Falkensammer, David Bante, et al.
Leukemia Research|February 14, 2012
The clinical impact of DNA methylation frequencies of JAK2 negative regulators in patients with essential thrombocythemiaMathilde Födermayr, Otto Zach, Maria Huber, et al.
BMC Cancer|July 9, 2016
Interleukin-22 is elevated in lavage from patients with lung cancer and other pulmonary diseasesAmanda Tufman, Rudolf Maria Huber, Stefanie Völk, et al.
Vaccine|February 9, 2007
Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccineRoland Grunow, Mustafa Porsch-Ozcürümez, Wolf Splettstoesser, et al.
Plos One|December 3, 2015
Correction: Risk Factors for Mercury Exposure of Children in a Rural Mining Town in Northern ChileJohan Ohlander, Stella Maria Huber, Michael Schomaker, et al.
Pageof 9